Abraham Silji 4
4 · WEST PHARMACEUTICAL SERVICES INC · Filed Aug 10, 2023
Insider Transaction Report
Form 4
Abraham Silji
Chief Digital & Trans Officer
Transactions
- Exercise/Conversion
Common Stock
2023-08-08$102.51/sh+8,160$836,482→ 12,369.3 total - Sale
Common Stock
2023-08-08$397.18/sh−8,154$3,238,586→ 4,215.3 total - Sale
Common Stock
2023-08-08$397.69/sh−6$2,386→ 4,209.3 total - Exercise/Conversion
Stock Options (Right to buy)
2023-08-08$102.51/sh−8,160$836,482→ 0 totalExercise: $102.51From: 2020-02-19Exp: 2029-02-19→ Common Stock (8,160 underlying)
Footnotes (2)
- [F1]The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $396.53 to $397.285, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
- [F2]This option is fully vested.